We wouldn’t fault Aurinia Pharmaceuticals Inc. (TSE: AUP) investors if they were a little stressed over the way that Chin-Kyu Huh, an organization insider, as of late got about CA$1.4m selling shares at a normal cost of CA$25.90. Nonetheless, it’s critical to take note of that they stay especially put resources into the auph stock at https://www.webull.com/quote/nasdaq-auph and that deal just decreased their holding by 1.6%.
Insider exchanging subtleties